BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1706548)

  • 1. The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses.
    Gould AR; Eaton BT
    Virus Res; 1990 Nov; 17(3):161-72. PubMed ID: 1706548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphogenesis of a bluetongue virus variant with an amino acid alteration at a neutralization site in the outer coat protein, VP2.
    Gould AR; Hyatt AD; Eaton BT
    Virology; 1988 Jul; 165(1):23-32. PubMed ID: 2838961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic relationships of the VP2 protein of a virulent isolate of bluetongue virus (BTV-23) compared to those of 6 other BTV serotypes.
    Yamakawa M; Krasnyck V; Roy P
    Virus Res; 1994 Oct; 34(1):81-92. PubMed ID: 7831967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization determinants of United States bluetongue virus serotype ten.
    DeMaula CD; Heidner HW; Rossitto PV; Pierce CM; MacLachlan NJ
    Virology; 1993 Jul; 195(1):292-6. PubMed ID: 7686312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup.
    White JR; Eaton BT
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1325-32. PubMed ID: 1693664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A complex neutralization domain of bluetongue virus serotype 17 defines a virulence-associated marker.
    Bernard KA; Israel BA; Schultz KT
    Viral Immunol; 1996; 9(2):97-106. PubMed ID: 8822626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an amino acid on VP2 that affects neutralization of bluetongue virus serotype 10.
    Jewell JE; Mecham JO
    Virus Res; 1994 Aug; 33(2):139-44. PubMed ID: 7975878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies.
    DeMaula CD; Bonneau KR; MacLachlan NJ
    Virus Res; 2000 Mar; 67(1):59-66. PubMed ID: 10773319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bluetongue virus serotype 17 sequence variation associated with neutralization.
    Wilson WC; Bernard KA; Israel BA; Mecham JO
    DNA Seq; 2008 Jun; 19(3):237-40. PubMed ID: 17852347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships amongst bluetongue viruses revealed by comparisons of capsid and outer coat protein nucleotide sequences.
    Gould AR; Pritchard LI
    Virus Res; 1990 Aug; 17(1):31-52. PubMed ID: 2171239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
    Hwang GY; Li JK
    Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the bluetongue virus neutralization protein VP2.
    Fukusho A; Ritter GD; Roy P
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2967-73. PubMed ID: 2824673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete sequence of neutralization protein VP2 of the recent US isolate bluetongue virus serotype 2: its relationship with VP2 species of other US serotypes.
    Yamaguchi S; Fukusho A; Roy P
    Virus Res; 1988 Aug; 11(1):49-58. PubMed ID: 2845683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence and cognitive analyses of two virulence-associated markers of bluetongue virus serotype 17.
    Bernard KA; Israel BA; Wilson WC; Schultz KT
    Intervirology; 1997; 40(4):226-31. PubMed ID: 9612723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17.
    Pierce CM; Rossitto PV; MacLachlan NJ
    Virology; 1995 May; 209(1):263-7. PubMed ID: 7538255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved and non-conserved regions of the outer coat protein, VP2, of the Australian bluetongue serotype 1 virus, revealed by sequence comparison to the VP2 of North American BTV serotype 10.
    Gould AR
    Virus Res; 1988 Feb; 9(2-3):145-58. PubMed ID: 2833046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the outer capsid protein, VP2, from a full length cDNA clone of genome segment 2 of bluetongue serotype 1 from South Africa, using both Sp6 and vaccinia expression systems and a comparison of the nucleic acid sequence of this segment with those of other serotypes.
    Wade-Evans AM; Mertens PP
    Virus Res; 1990 Mar; 15(3):213-29. PubMed ID: 2160764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segment-2 sequencing and cross-neutralization studies confirm existence of a neutralization resistant VP2 phenotypic variant of bluetongue virus serotype 1 in India.
    Biswas SK; Chand K; Rehman W; Reddy YN; Mondal B
    Vet Microbiol; 2015 Apr; 176(3-4):358-64. PubMed ID: 25703157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of antigenic epitopes of monoclonal antibodies against the VP2 protein of the 25 serotype of bluetongue virus.
    Xie S; Shi Y; Gong R; Cui W; Jiang Y; Liu M; Wang L; Zhou H; Qiao X; Li Y; Xu Y; Tang L
    Vet Microbiol; 2018 Jun; 219():136-143. PubMed ID: 29778186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.